Altered apoptosis-related signaling after cardioplegic arrest in patients with uncontrolled type 2 diabetes mellitus

Circulation

Volumn 128, Issue SUPPL.1, 2013, Pages

  Feng, Jun ^a   Liu, Yuhong ^a   Dobrilovic, Nikola ^a   Chu, Louis M ^a   Bianchi, Cesario ^a   Singh, Arun K ^a   Sellke, Frank W ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Apoptosis; Cardioplegia; Cardiopulmonary bypass; Coronary artery bypass surgery; Diabetes mellitus

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 3; CASPASE 8; CASPASE 9; DNA NUCLEOTIDYLEXOTRANSFERASE; HEMOGLOBIN A1C; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE C;

AGED; APOPTOSIS; ARTERY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART ARREST; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION; SIGNAL TRANSDUCTION;

APOPTOSIS; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS;

AGED; APOPTOSIS; ATRIAL APPENDAGE; CARDIOPLEGIC SOLUTIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEART ARREST; HEART ARREST, INDUCED; HUMANS; MALE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; PILOT PROJECTS;

EID: 84883778672     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.000332     Document Type: Article

References (24)

1. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
2. Thourani VH, Weintraub WS, Stein B, Gebhart SS, Craver JM, Jones EL, Guyton RA. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999;67:1045-1052.
3. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet. 1996;347:444-445.
4. Cai L, Kang YJ. Oxidative stress and diabetic cardiomyopathy: A brief review. Cardiovasc Toxicol. 2001;1:181-193.
5. Ritchie RH, Love JE, Huynh K, Bernardo BC, Henstridge DC, Kiriazis H, Tham YK, Sapra G, Qin C, Cemerlang N, Boey EJ, Jandeleit-Dahm K, Du XJ, McMullen Jr. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes. Diabetologia. 2012;55:3369-3381.
6. Ares-Carrasco S, Picatoste B, Benito-Martin A, Zubiri I, Sanz AB, Sanchez-Nino MD, Ortiz A, Egido J, Tunon J, Lorenzo O. Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes. Am J Physiol. 2009;297:H2109-H2119.
7. Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD Trial Group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial. Lancet. 2010;376:419-430.
8. Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ. ACCORD Study Group; ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363:233-244.
9. Furnary AP. Rationale for glycemic control in cardiac surgical patients: The portland diabetic project. Insulin. 2006;1:S24-S29.
10. Feng J, Liu Y, Khabbaz KR, Hagberg R, Robich MP, Clements RT, Bianchi C, Sellke FW. Decreased contractile response to endothelin-1 of peripheral microvasculature from diabetic patients. Surgery. 2011;149:247-252.
11. Feng J, Liu Y, Chu LM, Singh AK, Dobrilovic N, Fingleton JG, Clements RT, Bianchi C, Sellke FW. Changes in microvascular reactivity after cardiopulmonary bypass in patients with poorly controlled versus controlled diabetes. Circulation. 2012;126(11 suppl 1):S73-S80.
12. Feng J, Chu LM, Robich M, Clements RT, Khabbaz K, Hagberg R, Liu YH, Osipov RM, Sellke FW. Endothelin-1 induced contraction and signaling in the human skeletal muscle microcirculation. Circulation. 2010;122:S150-S155.
13. Feng J, Bianchi C, Sandmeyer JL, Li JY, Sellke FW. Molecular indices of apoptosis after intermittent blood and crystalloid cardioplegic ischemia. Circulation. 2005;112: I184-I119.
14. Feng J, Bianchi C, Li JY, Sellke FW. Improved profile of bad phosphorylation and caspase 3 activation after blood vs. crystalloid cardioplegia. Ann Thorac Surg. 2004;77:1384-1390.
15. Feng J, Bianchi C, Sandmeyer JL, Sellke FW. Bradykinin preconditioning improves the profile of cell survival proteins and limits apoptosis after cardioplegic arrest. Circulation. 2005;112(9 suppl):I190-I195.
16. Ramlawi B, Feng J, Mieno S, Szabo C, Zsengeller Z, Clements R, Sodha N, Boodhwani M, Bianchi C, Sellke FW. Indices of apoptosis activation after blood cardioplegia and cardiopulmonary bypass. Circulation. 2006;114(1 suppl):I257-I263.
17. Anselmi A, Abbate A, Girola F, Nasso G, Biondi-Zoccai GG, Possati G, Gaudino M. Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: A review of evidence. Eur J Cardiothorac Surg. 2004;25:304-311.
18. Aebert H, Kirchner S, Keyser A, Birnbaum DE, Holler E, Andreesen R, Eissner G. Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg. 2000;18:589-593.
19. Schmitt JP, Schröder J, Schunkert H, Birnbaum DE, Aebert H. Role of apoptosis in myocardial stunning after open heart surgery. Ann Thorac Surg. 2002;73:1229-1235.
20. Vähäsilta T, Malmberg M, Saraste A, Koskenvuo JW, Pärkkä JP, Valtonen M, Leino K, Nuutila K, Saukko P, Kuttila K, Savunen T. Cardiomyocyte apoptosis after antegrade and retrograde cardioplegia during aortic valve surgery. Ann Thorac Surg. 2011;92:1351-1357.
21. Osipov RM, Robich MP, Feng J, Chan V, Clements RT, Deyo RJ, Szabo C, Sellke FW. Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. Interact Cardiovasc Thorac Surg. 2010;10:506-512.
22. Chowdhry MF, Vohra HA, Galiñanes M. Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: Role of caspases and poly-adenosine diphosphate-ribose polymerase. J Thorac Cardiovasc Surg. 2007;134:124-31, 131.e1.
23. Anderson EJ, Rodriguez E, Anderson CA, Thayne K, Chitwood WR, Kypson AP. Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways. Am J Physiol Heart Circ Physiol. 2011;300:H118-H124.
24. Connelly KA, Kelly DJ, Zhang Y, Prior DL, Advani A, Cox AJ, Thai K, Krum H, Gilbert RE. Inhibition of protein kinase C in diabetic cardiomyopathy. Circ Heart Fail. 2009;2:129-137.